Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Neoplasms 4Thyroid Cancer, Papillary 1Differentiated Thyroid Cancer 1

Interventions

Thyrotropin Alfa 1Thyrotropin 1Thyroidectomy 1Thyroid (USP) 1Rosiglitazone 1Ritonavir 1Radiotherapy 1Radiofrequency Ablation 1Lymph Node Excision 1Iodine-131 1Indinavir 1Everolimus 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thyroid Cancer, Papillary × Iodine-131 × Clear all
NCT04354324 2024-03-15

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Zhujiang Hospital

Phase NA Unknown
254 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡